Clinical Trials in Tennessee

Showing 6081-6100 of 15,329 trials

Developmental Impact of NICU Exposures (DINE)

NCT03061890

The DINE study will test the hypothesis that potentially avoidable NICU-based exposures contribute to the neuro-cognitive and somatic impairments prevalent among NICU graduates. This hypothesis is drawn from the documented impact of phthalate exposure on early development in term-born children, and the acknowledged presence of these toxic chemicals in the NICU. Third trimester in utero exposure to phthalates have been linked to poorer childhood performance in cognition, motor function, attention, hyperactivity and social behavior. Phthalate exposure is also associated with altered onset of puberty and asthma. The multi-site cohort and approach will clarify the role of NICU-based phthalate exposure on high-prevalence clinical outcomes.

Prematurity

Albert Einstein College of Medicine600 participantsStarted Apr 2017

Jacksonville, Florida, United States • Boston, Massachusetts, United States • Minneapolis, Minnesota, United States +8 more locations

COMPLETED92 miles

Butterfly - Clinical Performance Study

NCT05800158

This prospective clinical performance study is a non-interventional, multi-center study to evaluate the assay performance of the COVID-19 test using upper respiratory specimens. Prospectively collected nasopharyngeal and anterior nasal swabs will be collected from each participant recruited in the study.

COVID-19Coronavirus Infections

Thermo Fisher Scientific, Inc1,076 participantsStarted Apr 2023

Manhattan Beach, California, United States • Redondo Beach, California, United States • San Diego, California, United States +8 more locations

Developmental Impact of NICU Exposures (DINE)

Butterfly - Clinical Performance Study

Find Trials by Condition in Tennessee

A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy

Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects

A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)

A Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

ORACLE-NIRS: Lipid cORe Plaque Association With CLinical Events: a Near-InfraRed Spectroscopy Study

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

Mite Asthma Pediatric Immunotherapy Trial

Alignment Comparison Between TruMatch™ Personalized Solutions and Conventional Total Knee Replacement Instrumentation

Open Label Study to Evaluate the Safety and Efficacy of Lenalidomide With MOR00208 in Patients With R-R DLBCL

SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer

Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors

A Study of HB0045 Injection in Patients With Advanced Solid Tumors

A Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Sitravatinib

Exacerbations and Their Outcomes International (EXACOS International)

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico